Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.
- Citation:
- Leuk Lymphoma vol 48 (7) 1313-9
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA33601, CA77597, CA77658, K23 CA109004-01A1
- Corr. Author:
- Authors:
- Kristie A Blum Jeffrey L Johnson Donna Niedzwiecki George P Canellos Bruce D Cheson Nancy L Bartlett
- Networks:
- Study
- CALGB-50206
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Boronic Acids, Bortezomib, Disease Progression, Female, Hodgkin Disease, Humans, Male, Middle Aged, Pyrazines, Salvage Therapy, Survival Analysis, Treatment Failure